The Manila Times10h
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Le Lézard11h
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2?-bias Bispecific Antibody Fusion Protein) in Melanoma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
GB News on MSN2d
Cancer: 'Doctors found 20 tumours - they all came from a small growth on my back that I ignored'
Helen Bender, from Alabama, United States, was devastated to learn she had 20 tumours, all originating from a seemingly ...
How melanoma and other tumors succeed in hiding and resisting immunotherapy
Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...
KEYTRUDA®Now Registered To Treat Malignant Pleural Mesothelioma, Biliary Tract Carcinoma & Merkel Cell Carcinoma
Biliary Tract Cancer (BTC): KEYTRUDA may be combined with chemotherapy medicines to treat BTC, a cancer that affects the bile ducts or gallbladder. This treatment is for adults when the cancer has ...